Latest AI and machine learning research in cardiovascular for healthcare professionals.
Large language models are increasingly used to generate patient information in healthcare. However, ...
The OncotypeDX 21-gene assay is a widely adopted tool for estimating recurrence risk and informing c...
Hepatic steatosis (HS) is a common cardiometabolic risk factor frequently present but under-diagnose...
The evaluation of erb-b2 receptor tyrosine kinase 2 (ERBB2 or HER2) gene amplification status throug...
Breast cancer is one of the most common cancers globally. Its incidence in Africa has increased shar...
Head and neck cancer (HNC) patients face an increased risk of malnutrition due to lifestyle, tumor l...
The tumor–stroma ratio (TSR) is an established prognostic biomarker across several cancer types, yet...
Deep learning models applied to digital histology can predict gene expression signatures (GES) and o...
A hallmark of glioblastoma (GBM) is disease recurrence, which occurs in all patients despite tumor r...
The health consequences of ionizing radiation have long been studied, yet significant uncertainties ...
This study evaluated the prognostic performance of RlapsRisk BC, a multimodal deep learning tool des...
The ability of pre-trained large language models (LLMs) to rapidly master novel natural language pro...
Thymic involution, characterized by adipose replacement of functional thymic tissue, is a broadly re...
Breast cancer, which is among the top causes of cancer-related deaths in women worldwide, demonstrat...
Radiotherapy treatment planning is a resource-intensive process characterized by multiple manual ste...
To prospectively evaluate the feasibility and performance of expedited screening mammogram interpret...
Up to 80% of women breast cancer survivors (BCS), particularly those treated with chemotherapy, repo...
Immune infiltration is prognostic in triple-negative breast cancer (TNBC), but its role in ER⁺/HER2⁻...
Homologous recombination deficiency (HRD) confers sensitivity to poly (ADP-ribose) polymerase (PARP)...
Neoadjuvant chemotherapy (NAC) is the standard of care for locally advanced breast cancer. However, ...
Early-onset colorectal cancer (EOCRC) continues to rise, with the steepest increases observed among ...